New

AI v2.0 Beta Launched. Experience the future of pharmaceutical care.

Try Now
Drug info language
Switches all medical info on this page (labels, indications, leaflet) without changing the rest of the interface.
CNASOTCTranslated

API E

100MG/Chewable Tablet/TOCOPHEROL
API
ManufacturerVerified lab

API

Public retail price
114.75DZD
Reference price (TR): 114.60 DZD

Identification

Active ingredient (INN)
TOCOPHEROL
Internal code
14 H 110
Country of Origin
Algeria
Pharmaceutical form
Chewable Tablet
Prescription List
OTC
Packaging
b/20
API E
Clinical View
CNAS

DAWA Clinical Workbench v2.0

Information may not be accurate. Always consult a physician, pharmacist, or specialist before acting on any data shown here.

Description

is a prescription prenatal/postnatal multivitamin/mineral/essential fatty acid softgel.

Each softgel is blue in color, opaque and imprinted with “BP 321” on one side.

Size 1 Tablet Amount Per Serving % DV %DV for Pregnant or Lactating Women Vitamin C 85 mg 142% 142% Vitamin D 3 200 IU 50% 50% Vitamin E 10 IU 33% 33% Vitamin D 6 25 mg 1250% 1000% Folate 1 mg 250% 125% (L-methylfolate calcium 676 mcg (as Xolafin-B™ Percent Daily Values are based on a 2000 calorie diet ) molar equivalent to 600 mcg of Folic Acid) (folic acid, USP 400 mcg) Vitamin B 12 12 mcg 200% 150% Calcium 140 mg 14% 11% Iron (ferrous fumarate) 27 mg 150% 150% Magnesium 45 mg 11% 10% Docosahexaenoic Acid (DHA) (from omega-3 fatty acids) 300 mg Daily Value (DV) not established OTHER INGREDIENTS: bee’s wax, hydrogenated vegetable oil, lecithin, gelatin, glycerin, purified water, titanium dioxide, FD&C Blue #1, FD&C Red #3.

PNV-DHA is a multivitamin/multimineral nutritional supplement indicated for use in the dietary management of patients with nutritional deficiencies or are in need of nutritional supplementation.

This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

Indications

is a multivitamin/multimineral nutritional supplement indicated for use in the dietary management of patients with nutritional deficiencies or are in need of nutritional supplementation.

Adverse Effects

Allergic sensitization has been reported following both oral and parenteral administration of folic acid.

Warnings

Ingestion of more than 3 grams of omega-3 fatty acids (such as DHA) per day has been shown to have potential antithrombotic effects, including an increased bleeding time and International Normalized Ratio (INR).

Administration of omega-3 fatty acids should be avoided in patients taking anticoagulants and in those known to have an inherited or acquired predisposition to bleeding.

Contraindications

This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

Dosage & Administration

Before, during and/or after pregnancy, one softgel daily or as directed by a physician.

How Supplied

is supplied in child-resistant bottles of 30 softgels (NDC# 42192-321-30).

Store at 20°.

  • 25°C (68° - 77°F); excursions permitted to 15°.
  • 30°C (59° - 86°F).

Alternatives